Advertisement
News
Subscribe to MDT Magazine News

Consumer Information on: Revo MRI SureScan Pacing System - P090013

February 24, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

The Revo MRI SureScan Pacing System is designed to deliver standard pacing therapy in patients who have slow heart rates (bradycardia). Unlike most other pacing systems, the Revo MRI SureScan Pacing System has been specifically designed and tested to...

TOPICS:

Summary Information for: Revo MRI SureScan Pacing System

February 24, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Revo MRI SureScan Pacing System (P090013).

TOPICS:

Fewer people sought unemployment aid last week

February 24, 2011 4:45 am | by CHRISTOPHER S. RUGABER - AP Economics Writer - Associated Press | Comments

Fewer people requested unemployment benefits last week, pushing the average number of applications over the past four weeks to the lowest level in more than two and a half years.Applications for unemployment benefits dropped by 22,000 last week to a seasonally adjusted 391,000, the Labor...

Advertisement

Charles River Labs begins $150M stock buyback

February 24, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Charles River Laboratories International Inc. has initiated an accelerated stock repurchase (ASR) program to buy back $150 million in common stock, as part of a larger $750 million stock buyback plan, the Wilmington company announced today.

Reportlinker Adds Global Computer Assisted Surgical (CAS) Systems Industry

February 24, 2011 4:36 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Computer Assisted Surgical (CAS) Systems Industry http://www.reportlinker.com/p0397748/Global-Computer-Assisted-Surgical-CAS-Systems-Industry.html This report...

TOPICS:

Thermo Fisher to sell two units for $940M

February 24, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Thermo Fisher Scientific Inc. said today it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

TOPICS:

Reportlinker Adds Global Drug-Eluting Stents Industry

February 24, 2011 4:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Drug-Eluting Stents Industry http://www.reportlinker.com/p080457/Global-Drug-Eluting-Stents-Industry.html This report analyzes the worldwide markets for...

TOPICS:

American Medical Systems Announces U.S. Launch of Concealâ„¢ Low Profile Reservoir for Penile Prosthetics

February 24, 2011 4:34 am | by Bio-Medicine.Org | Comments

MINNETONKA, Minn., Feb. 24, 2011 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the full U.S. launch of its new Conceal™ Low Profile Reservoir, an enhancement to the...

TOPICS:
Advertisement

West Appoints Two Directors and Announces Second Quarter 2011 Dividend

February 24, 2011 4:32 am | by Bio-Medicine.Org | Comments

LIONVILLE, Pa., Feb. 24, 2011 /- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors increased the size of the Board to twelve and appointed two new directors, Mr. Mark A. Buthman and Mr. Douglas A. Michels. Each of their terms are effective...

TOPICS:

TomoTherapy to Be Presented With American Cancer Society's "Corporate Distinguished Visionary Award"

February 24, 2011 3:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that, on Friday, February 25, the company will be presented with the "Corporate...

Gene Haas Machining Technology Scholarship Fund Provides $50,000 to Focus: HOPE Machinist Training Institute (MTI)

February 24, 2011 3:39 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 22, 2011 — Success breeds success. And at Focus: HOPE, the momentum is building for young men and women pursuing careers in the machinist trades. The SME Education Foundation has provided $50,000 from the Gene Haas Machining Technology Scholarship Fund to...

HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009

February 24, 2011 3:37 am | by Bio-Medicine.Org | Comments

FRAMINGHAM, Mass. and SYDNEY, Feb. 24, 2011 /- HeartWare International, Inc. (Nasdaq: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenues of $20.9...

TOPICS:

Royal Fornia Electronic Device Co., Ltd. Signs Technology Licensing Agreement to Integrate Masimo rainbow SET Pulse CO-Oximetry Into New Patient Monitors

February 24, 2011 3:37 am | by Bio-Medicine.Org | Comments

IRVINE, Calif. and GUANGDONG PROVINCE, China, Feb. 24, 2011 /- Masimo (Nasdaq: MASI ) and Royal Fornia Electronic Device Co., Ltd. jointly announce a worldwide technology licensing agreement to integrate Masimo rainbow SET® Pulse CO-Oximetry™ technology into Royal Fornia's new...

TOPICS:

NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring(2)

February 24, 2011 3:36 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Feb. 24, 2011 /- PR Newswire – NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing...

TOPICS:

Fatty liver may herald impending Type 2 diabetes

February 24, 2011 3:35 am | by EurekAlert | Comments

(The Endocrine Society) A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that individuals with fatty liver were five times more likely to develop Type 2 diabetes than those without fatty liver. This higher risk seemed...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading